Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Moreno-Bueno, G; Sanchez-Estevez, C; Cassia, R; Rodriguez-Perales, S; Diaz-Uriarte, R; Dominguez, O; Hardisson, D; Andujar, M; Prat, J; Matias-Guiu, X; Cigudosa, JC; Palacios, J

    Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas

    CANCER RESEARCH 63 5697-5702. .

  • Alvarez-Nunez, F; Mora, J; Matias-Guiu, X; Grp Estudio Marcadores Tumorales

    Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes

    MEDICINA CLINICA 121 264-269. .

    [doi:10.1157/13050439]

  • Moreno-Bueno, G; Rodriguez-Perales, S; Sanchez-Estevez, C; Hardisson, D; Sarrio, D; Prat, J; Cigudosa, JC; Matias-Guiu, X; Palacios, J

    Cyclin D1 gene (CCND1) mutations in endometrial cancer

    ONCOGENE 22 6115-6118. .

    [doi:10.1038/sj.onc.1206868]

  • Bellido, M; Aventin, A; Lasa, A; Estivill, C; Carnicer, MJ; Pons, C; Matias-Guiu, X; Bordes, R; Baiget, M; Sierra, J; Nomdedeu, JF

    Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia

    HAEMATOLOGICA 88 994-1001. .

  • Ota, S; Catasus, L; Matias-Guiu, X; Bussaglia, E; Lagarda, H; Pons, C; Munoz, J; Kamura, T; Prat, J

    Molecular pathology of atypical polypoid adenomyoma of the uterus

    HUMAN PATHOLOGY 34 784-788. .

    [doi:10.1016/S0046-8177(03)00246-6]

  • Moreno-Bueno, G; Hardisson, D; Sarrio, D; Sanchez, C; Cassia, R; Prat, J; Herman, JG; Esteller, M; Matias-Guiu, X; Palacios, L

    Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120(ctn)) expression in endometrial cancer and endometrial atypical hyperplasia

    JOURNAL OF PATHOLOGY 199 471-478. .

    [doi:10.1002/path.1310]

  • Matias-Guiu, X; Prat, J

    Bifunctional pathway of uterine carcinosarcomas - Reply

    HUMAN PATHOLOGY 34 300-300. .

    [doi:10.1053/hupa.2003.21]

  • Madas-Guiu, X; Catasus, L; Lagarda, H; Palomar, V; Quer, M

    Germ-line mutations in the SDHD gene in patients with familial paraganglioma

    Modern Pathology 16 478-478. .

  • Lloreta, J; Domingo, P; Pujol, RM; Arroyo, JA; Baixeras, N; Matias-Guiu, X; Gilaberte, M; Sambeat, MA; Serrano, S

    Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy

    VIRCHOWS ARCHIV 441 599-604. .

    [doi:10.1007/s00428-002-0667-0]

  • Moreno-Bueno, G; Hardisson, D; Sanchez, C; Sarrio, D; Cassia, R; Garcia-Rostan, G; Prat, J; Guo, MZ; Herman, JG; Matias-Guiu, X; Esteller, M; Palacios, J

    Abnormalities of the aPC/beta-catenin pathway in endometrial cancer

    ONCOGENE 21 7981-7990. .

    [doi:10.1038/sj.onc.1205924]

  • Machin, P; Catasus, L; Pons, C; Munoz, J; Conde-Zurita, JM; Balmana, J; Barnadas, M; Marti, RM; Prat, J; Matias-Guiu, X

    Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.

    JOURNAL OF CUTANEOUS PATHOLOGY 29 415-420. .

    [doi:10.1034/j.1600-0560.2002.290705.x]

  • Matias-Guiu, X; Lagarda, H; Catasus, L; Bussaglia, E; Gallardo, A; Gras, E; Prat, J

    Clonality analysis in synchronous or metachronous tumors of the female genital tract

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 21 205-211. .

    [doi:10.1097/00004347-200207000-00001]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU